Paul B. Chretien

4.6k total citations
128 papers, 3.6k citations indexed

About

Paul B. Chretien is a scholar working on Oncology, Immunology and Surgery. According to data from OpenAlex, Paul B. Chretien has authored 128 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Oncology, 40 papers in Immunology and 28 papers in Surgery. Recurrent topics in Paul B. Chretien's work include Cancer Immunotherapy and Biomarkers (20 papers), Immunotherapy and Immune Responses (16 papers) and Immune Cell Function and Interaction (12 papers). Paul B. Chretien is often cited by papers focused on Cancer Immunotherapy and Biomarkers (20 papers), Immunotherapy and Immune Responses (16 papers) and Immune Cell Function and Interaction (12 papers). Paul B. Chretien collaborates with scholars based in United States, Hungary and Switzerland. Paul B. Chretien's co-authors include William J. Catàlona, Claude Potvin, W. Frederick Sample, John C. Alexander, A. Lee Dellon, John L. Tarpley, Norman A. Silverman, Alfred S. Ketcham, Peyton T. Taylor and Robert C. Hoye and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Paul B. Chretien

125 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul B. Chretien United States 36 1.3k 996 779 584 527 128 3.6k
Thomas Kirchner Germany 33 1.3k 1.0× 1.0k 1.0× 962 1.2× 464 0.8× 920 1.7× 118 4.5k
William S. Fletcher United States 33 1.8k 1.4× 196 0.2× 1.1k 1.4× 443 0.8× 536 1.0× 143 3.5k
Shinichiro Okamoto Japan 41 1.5k 1.1× 1.1k 1.1× 674 0.9× 875 1.5× 1.1k 2.1× 389 7.1k
P.H.M. de Mulder Netherlands 28 1.1k 0.8× 429 0.4× 1.3k 1.7× 146 0.3× 765 1.5× 116 3.1k
Sepp Leodolter Austria 38 1.2k 0.9× 616 0.6× 1.2k 1.5× 1.9k 3.2× 1.5k 2.9× 181 5.5k
L E Hughes United Kingdom 38 1.1k 0.9× 404 0.4× 1.7k 2.2× 520 0.9× 653 1.2× 120 4.2k
Gordon L. Phillips United States 26 1.0k 0.8× 643 0.6× 780 1.0× 382 0.7× 476 0.9× 87 3.8k
A. Ayhan Türkiye 40 1.2k 0.9× 516 0.5× 968 1.2× 400 0.7× 1.7k 3.3× 224 5.3k
Siegfried Segaert Belgium 30 816 0.6× 1.1k 1.1× 250 0.3× 626 1.1× 401 0.8× 69 3.3k
G. Bastert Germany 37 2.8k 2.2× 822 0.8× 565 0.7× 351 0.6× 1.0k 2.0× 216 5.3k

Countries citing papers authored by Paul B. Chretien

Since Specialization
Citations

This map shows the geographic impact of Paul B. Chretien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul B. Chretien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul B. Chretien more than expected).

Fields of papers citing papers by Paul B. Chretien

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul B. Chretien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul B. Chretien. The network helps show where Paul B. Chretien may publish in the future.

Co-authorship network of co-authors of Paul B. Chretien

This figure shows the co-authorship network connecting the top 25 collaborators of Paul B. Chretien. A scholar is included among the top collaborators of Paul B. Chretien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul B. Chretien. Paul B. Chretien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cartier, André, et al.. (1999). Aerosolized snow‐crab allergens in a processing facility. Allergy. 54(8). 892–893. 28 indexed citations
2.
Cummings, G. D., et al.. (1992). Serum levels of immunoreactive thymosin alpha 1 and thymosin beta 4 in large cohorts of healthy adults.. PubMed. 19(1). 45–52. 22 indexed citations
3.
Sugarbaker, Everett V., et al.. (1982). Anorectal melanoma. Diseases of the Colon & Rectum. 25(8). 772–777. 10 indexed citations
4.
Montague, Paul, et al.. (1977). Intracellular localization of tumor-associated antigens in murine and human malignant melanoma.. PubMed. 37(5). 1519–24. 14 indexed citations
5.
7.
Hollinshead, Ariel C., et al.. (1976). In vivo and in vitro measurements of the relationship of human squamous carcinomas to herpes simplex virus tumor-associated antigens.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 36(2 pt 2). 821–8. 36 indexed citations
8.
Dellon, A. Lee, Thomas M. Tarpley, & Paul B. Chretien. (1976). Histologic evaluation of intraoral skin grafts and pedicle flaps in humans.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 34(9). 789–94. 22 indexed citations
9.
Dellon, A. Lee, Richard L. Edelson, & Paul B. Chretien. (1976). DEFINING THE MALIGNANT POTENTIAL OF THE GIANT PIGMENTED NEVUS. Plastic & Reconstructive Surgery. 57(5). 611–618. 37 indexed citations
10.
Wexler, Hilda, Paul B. Chretien, Alfred S. Ketcham, & William F. Sindelar. (1975). Induction of pulmonary metastases in both immune and nonimmune mice: Effect of the removal of a transplanted primary tumor. Cancer. 36(6). 2042–2047. 1 indexed citations
11.
Johnson, R. E., V. T. DeVita, Larry E. Kun, et al.. (1975). Patterns of involvement with malignant lymphoma and implications for treatment decision making.. PubMed. 2. 237–41. 19 indexed citations
12.
Catàlona, William J., Claude Potvin, John L. Tarpley, & Paul B. Chretien. (1974). T Rosette assay In vitro correlate of cellular immunity. Urology. 4(1). 100–104. 1 indexed citations
13.
Twomey, Patrick, William J. Catàlona, & Paul B. Chretien. (1974). Cellular immunity in cured cancer patients. Cancer. 33(2). 435–440. 79 indexed citations
14.
Catàlona, William J., Paul B. Chretien, & Emile Trahan. (1974). Abnormalities of Cell-Mediated Immunocompetence in Genitourinary Cancer. The Journal of Urology. 111(2). 229–232. 51 indexed citations
15.
Ketcham, Alfred S., Paul B. Chretien, John M. Van Buren, et al.. (1973). The ethmoid sinuses: A re-evaluation of surgical resection. The American Journal of Surgery. 126(4). 469–476. 119 indexed citations
16.
Ketcham, Alfred S., Paul B. Chretien, Robert C. Hoye, et al.. (1973). OCCULT METASTASES TO THE SCALENE LYMPH NODES IN PATIENTS WITH CLINICALLY OPERABLE CARCINOMA OF THE CERVIX. Obstetrical & Gynecological Survey. 28(6). 441–441.
17.
Cullen, Bruce F., Paul B. Chretien, & Brigid G. Leventhal. (1972). THE EFFECT OF LIGNOCAINE ON PHA-STIMULATED HUMAN LYMPHOCYTE TRANSFORMATION. British Journal of Anaesthesia. 44(12). 1247–1252. 20 indexed citations
18.
Catàlona, William J., Peyton T. Taylor, Alan S. Rabson, & Paul B. Chretien. (1972). A Method for Dinitrochlorobenzene Contact Sensitization. New England Journal of Medicine. 286(8). 399–402. 187 indexed citations
19.
Futrell, J. William, G. R. F. Krueger, Paul B. Chretien, & Alfred S. Ketcham. (1971). Multiple primary sweat gland carcinomas. Cancer. 28(3). 686–691. 33 indexed citations
20.
Sample, W. Frederick & Paul B. Chretien. (1971). Thymidine kinetics in human lymphocyte transformation: determination of optimal labelling conditions.. PubMed. 9(3). 419–27. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026